SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RCUS

Arcus Biosciences, Inc. (New York Stock Exchange:RCUS)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
17.91-0.64 (-3.43%)
 
Market cap
$2.25B
Analyst consensus
Listed since
Mar 14, 2018
Insider Score
––Not scored
RCUS Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

RCUS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New RCUS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to RCUS from public contracts

Source: USAspending.gov

Recently reported changes in RCUS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing RCUS, reported under the STOCK Act.

PoliticianChamberActionAmountDate
No congressional trades recorded for RCUS.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.